2005 Annual Meeting | Genetics in Neurology

Date Friday 04/15/05

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Stefan M. Pulst, MD, FAAN

Topic(s) Neurogenetics/Neurometabolic Disorders/Neurotoxicology

Learning Objectives Upon completion:
Participants should be able to incorporate new developments in the genetics and molecular mechanisms of inherited neurological diseases.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
09:00 AM - 09:45 AM		Phakomatoses Stefan M. Pulst, MD, FAAN
09:45 AM - 10:30 AM		DNA Repeat Mutations Henry L. Paulson, MD, PhD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		Movement Disorders Christine Klein, MD
11:30 AM - 12:15 PM		Inherited Myopathies Katherine D. Mathews, MD, FAAN
12:15 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Inherited Neuropathies Phillip F. Chance, MD
02:15 PM - 03:00 PM		Migrane and Stroke Jeffery Gulcher, MD, PhD
03:00 PM - 03:15 PM		Break
03:15 PM - 04:00 PM		Genetics of Dementia Thomas D. Bird, MD, FAAN
04:00 PM - 04:45 PM		Molecular and Ethical Issues in DNA Testing Martha A. Nance, MD
04:45 PM - 05:00 PM		Population Testing: the Icelandic Experience Jeffery Gulcher, MD, PhD

Faculty Disclosures
Henry L. Paulson, MD, PhD, FAAN	Dr. Paulson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exicure. The institution of Dr. Paulson has received research support from National Institutes of Health. Dr. Paulson has a non-compensated relationship as a Member, Nominating committee with American Neurological Association that is relevant to AAN interests or activities.
Thomas D. Bird, MD, FAAN	Dr. Bird has nothing to disclose.
Stefan M. Pulst, MD, FAAN	Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Christine Klein, MD	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Phillip F. Chance, MD	No disclosure on file
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Jeffery Gulcher, MD, PhD	No disclosure on file
Martha A. Nance, MD	Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROche. Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. An immediate family member of Dr. Nance has received stock or an ownership interest from Fresca. The institution of Dr. Nance has received research support from HDSA. The institution of Dr. Nance has received research support from Parkinson Foundation. Dr. Nance has received research support from Parkinson Foundation. The institution of Dr. Nance has received research support from Neuraly. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a speaker with AAN.

��ɫ��

��ɫ��